CN Patent

CN114929211B — 胆汁酸和苯丁酸化合物的组合物

Assigned to Amylyx Pharmaceuticals Inc · Expires 2024-08-20 · 2y expired

What this patent protects

本公开涉及包含苯丁酸化合物和胆汁酸的组合物，以及加工这样的组合物的方法。

USPTO Abstract

本公开涉及包含苯丁酸化合物和胆汁酸的组合物，以及加工这样的组合物的方法。

Drugs covered by this patent

sodium-phenylbutyrate (SODIUM PHENYLBUTYRATE)

Patent Metadata

Patent number: CN114929211B
Jurisdiction: CN
Classification: —
Expires: 2024-08-20
Drug substance claim: No
Drug product claim: No
Assignee: Amylyx Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.